The objective is to produce new imaging probes and associated protocols for preclinical biomedical research and for clinical use in humans. The first specific aim is to discover small synthetic molecules that selectively target anionic cell membrane surfaces with exposed phosphatidylserine and distinguish them from the near-neutral membrane surfaces of healthy cells. One application is cell death imaging, as a method to detect disease and measure treatment efficacy. Preliminary work has shown that a family of fluorescent zinc coordination complexes can act as optical imaging probes for dead and dying tissue in various cell and animal models. The selectivity over healthy tissue is very high, even though binding affinities for exposed phosphatidylserine are moderate (low micromolar dissociation constants). To improve cell targeting performance for clinical applications, a systematic cycle of synthesis and screening will be employed to find next-generation compounds that have 500-fold higher binding affinity for phosphatidylserine. This will enable microdosing, which is the key to successful translation. The imaging ability of lead compounds will be evaluated in cell culture and animal models of cell death with a focus on producing the first set of practically useful, optical imaging probes for non-invasive assessment of the efficacy of anticancer therapies. The second specific aim is to create a new paradigm for planar optical imaging of tumors using near-infrared chemiluminescent and fluorescent (CLF) nanoparticles. The chemiluminescence is thermally-activated (that is, no chemical or electrical stimulus is needed) which means that the nanoparticles can be stored at low temperature and they only become chemiluminescent when warmed to body temperature. Preliminary results in mice show that chemiluminescence imaging permits identification of target sites that are more than two centimeters below the animal surface, which is about five times deeper than currently achieved using planar fluorescence imaging. The new imaging paradigm will be demonstrated by conducting experiments using relatively deep-tissue animal models of spontaneous prostate cancer and orthotopic colon cancer. Chemiluminescence imaging will be used to locate the tumor tissue that is targeted by the nanoparticles, and fluorescence microscopy of thin histology sections taken from the same specimen will quantify uptake into the tumor parenchyma. The power of this new imaging technology will be employed to answer questions concerning the ability of the tumor vascular-penetrating peptide iRGD to promote nanoparticle entry into tumors.

Public Health Relevance

High performance imaging probes for cell death will facilitate the diagnosis and treatment of disease in diverse medical fields such as oncology, cardiology, organ transplantation, neurology, ophthalmology, and autoimmune disease. New chemiluminescent and fluorescent probes for planar optical imaging will accelerate efforts to develop effective tumor imaging and treatment methods.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM059078-13A1
Application #
8234439
Study Section
Synthetic and Biological Chemistry A Study Section (SBCA)
Program Officer
Chin, Jean
Project Start
1999-05-01
Project End
2016-03-31
Budget Start
2012-04-01
Budget End
2013-03-31
Support Year
13
Fiscal Year
2012
Total Cost
$349,600
Indirect Cost
$119,600
Name
University of Notre Dame
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
824910376
City
Notre Dame
State
IN
Country
United States
Zip Code
46556
Peck, Evan M; Battles, Paul M; Rice, Douglas R et al. (2016) Pre-Assembly of Near-Infrared Fluorescent Multivalent Molecular Probes for Biological Imaging. Bioconjug Chem 27:1400-10
Harmatys, Kara M; Musso, Anthony J; Clear, Kasey J et al. (2016) Small molecule additive enhances cell uptake of 5-aminolevulinic acid and conversion to protoporphyrin IX. Photochem Photobiol Sci 15:1408-1416
Clear, Kasey J; Harmatys, Kara M; Rice, Douglas R et al. (2016) Phenoxide-Bridged Zinc(II)-Bis(dipicolylamine) Probes for Molecular Imaging of Cell Death. Bioconjug Chem 27:363-75
Rice, Douglas R; Clear, Kasey J; Smith, Bradley D (2016) Imaging and therapeutic applications of zinc(ii)-dipicolylamine molecular probes for anionic biomembranes. Chem Commun (Camb) 52:8787-801
Rice, Douglas R; Vacchina, Paola; Norris-Mullins, Brianna et al. (2016) Zinc(II)-Dipicolylamine Coordination Complexes as Targeting and Chemotherapeutic Agents for Leishmania major. Antimicrob Agents Chemother 60:2932-40
Liu, Wenqi; Peck, Evan M; Smith, Bradley D (2016) High Affinity Macrocycle Threading by a Near-Infrared Croconaine Dye with Flanking Polymer Chains. J Phys Chem B 120:995-1001
Guha, Samit; Shaw, Gillian Karen; Mitcham, Trevor M et al. (2016) Croconaine rotaxane for acid activated photothermal heating and ratiometric photoacoustic imaging of acidic pH. Chem Commun (Camb) 52:120-3
Clear, Kasey J; Virga, Katelyn; Gray, Lawrence et al. (2016) Using membrane composition to fine-tune the pK a of an optical liposome pH sensor. J Mater Chem C Mater Opt Electron Devices 4:2925-2930
Rice, Douglas R; White, Alexander G; Leevy, W Matthew et al. (2015) Fluorescence Imaging of Interscapular Brown Adipose Tissue in Living Mice. J Mater Chem B Mater Biol Med 3:1979-1989
Liu, Wenqi; Peck, Evan M; Hendzel, Kevin D et al. (2015) Sensitive Structural Control of Macrocycle Threading by a Fluorescent Squaraine Dye Flanked by Polymer Chains. Org Lett 17:5268-71

Showing the most recent 10 out of 73 publications